Your browser doesn't support javascript.
loading
Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical Evidence.
Kawanami, Daiji; Matoba, Keiichiro; Sango, Kazunori; Utsunomiya, Kazunori.
Affiliation
  • Kawanami D; Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan. daijika@jikei.ac.jp.
  • Matoba K; Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan. matoba@jikei.ac.jp.
  • Sango K; Diabetic Neuropathy Project, Department of Sensory and Motor Systems, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan. sango-kz@igakuken.or.jp.
  • Utsunomiya K; Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan. kazu-utsunomiya@jikei.ac.jp.
Int J Mol Sci ; 17(8)2016 Jul 29.
Article in En | MEDLINE | ID: mdl-27483245
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Diabetes Complications / Dipeptidyl-Peptidase IV Inhibitors / Incretins / Glucagon-Like Peptide-1 Receptor / Hypoglycemic Agents Limits: Humans Language: En Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Diabetes Complications / Dipeptidyl-Peptidase IV Inhibitors / Incretins / Glucagon-Like Peptide-1 Receptor / Hypoglycemic Agents Limits: Humans Language: En Year: 2016 Type: Article